What are the causes of polycythemia in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Polycythemia in Children

Primary Classification Framework

Polycythemia in children results from three major mechanisms: apparent (relative) polycythemia due to plasma volume depletion, primary clonal disorders, or secondary causes driven by either hypoxia-dependent or hypoxia-independent mechanisms. 1


Apparent (Relative) Polycythemia

Relative polycythemia occurs when plasma volume decreases without true increase in red cell mass: 1

  • Severe dehydration from diarrhea, vomiting, or inadequate fluid intake 1
  • Diuretic use causing plasma volume contraction 1
  • Severe burns with capillary leak and fluid shifts 1
  • Capillary leak syndrome 1

These conditions are clinically obvious and do not require specialized hematologic testing. 1


Primary Polycythemia

Polycythemia Vera (Rare in Children)

  • JAK2-mutated myeloproliferative neoplasm with clonal erythrocytosis 1
  • Characterized by low or inappropriately normal serum erythropoietin (EPO) levels 1, 2
  • JAK2 V617F mutation present in up to 97% of cases 1, 3
  • Often presents with thrombocytosis, leukocytosis, and panmyeloid hyperplasia 1

Primary Familial and Congenital Polycythemia (PFCP)

  • Autosomal dominant condition caused by gain-of-function mutations in the erythropoietin receptor (EPOR) gene 4, 5
  • Characterized by low EPO levels and increased erythroid precursor responsiveness to EPO 4
  • Erythroid compartment expands independently of extrinsic influences 5

Secondary Polycythemia: Hypoxia-Driven Causes

Cyanotic Congenital Heart Disease

The most clinically important cause of polycythemia in children is cyanotic congenital heart disease with right-to-left shunting. 6

  • Right-to-left shunting causes systemic arterial oxygen desaturation and tissue hypoxia 6
  • Kidneys release erythropoietin to stimulate red cell production (erythrocytosis) in response to hypoxia 6
  • Aortic oxygen saturations <75% represent the critical threshold below which decompensated erythrocytosis occurs 6
  • EPO levels remain elevated as the body attempts to achieve normal tissue oxygenation by increasing red cell mass and hemoglobin concentration (decompensated erythrocytosis) 6

Critical pitfall: Iron deficiency commonly develops as red cell mass increases, creating microcytic hypochromic red cells that are rigid, less deformable in capillaries, and have decreased oxygen-carrying capacity—paradoxically worsening tissue oxygenation. 6

Chronic Lung Disease

  • Chronic obstructive pulmonary disease (COPD) triggers compensatory erythropoiesis through tissue hypoxia 1, 3
  • Pulmonary fibrosis causes chronic hypoxemia 1
  • Hypoventilation syndromes including obstructive sleep apnea cause chronic intermittent hypoxia 1, 3

High-Altitude Exposure

  • High-altitude habitation leads to physiologic polycythemia as adaptive response to reduced atmospheric oxygen 1, 3
  • Symptomatic high-altitude pulmonary hypertension (SHAPH) most commonly afflicts infants and children, primarily offspring of Chinese Han ancestry who moved from low altitude to Qinghai-Tibet Plateau above 3000 m 6
  • Unlike Monge disease, patients with SHAPH do not present with polycythemia 6

Congenital Hemoglobin Disorders

  • High oxygen-affinity hemoglobinopathies (autosomal dominant) cause low tissue oxygen tension despite normal arterial oxygen saturation 4, 5, 7
  • Methemoglobinemia reduces oxygen delivery to tissues 4
  • 2,3-bisphosphoglycerate (2,3-BPG) deficiency or 2,3-bisphosphoglycerate mutase deficiency increases hemoglobin-oxygen affinity, reducing oxygen release to tissues 4, 5, 7

Secondary Polycythemia: Hypoxia-Independent Causes

Defective Hypoxia Sensing

  • Von Hippel-Lindau (VHL) gene mutations (homozygous or compound heterozygous) cause inappropriately normal or elevated EPO despite normoxia and erythrocytosis 4, 5
  • Chuvash polycythemia represents abnormal oxygen homeostasis with elevated EPO set point 3
  • Affected children have high risk of arterial thrombosis and early mortality 4

Tumor-Associated Erythrocytosis (Rare in Children)

  • Renal cell carcinoma produces EPO independently of hypoxia 1, 3
  • Hepatocellular carcinoma produces EPO autonomously 1, 3
  • Cerebellar hemangioblastoma (associated with VHL disease) produces EPO 1
  • Wilms tumor and other pediatric renal tumors may produce EPO 1

Exogenous Causes

  • Exogenous erythropoietin administration or androgen preparations 3

Diagnostic Algorithm for Pediatric Polycythemia

Step 1: Confirm True Polycythemia

  • Verify hemoglobin/hematocrit values are truly elevated beyond age-, sex-, and race-adjusted normal values 1, 2
  • Assess for clinically obvious plasma volume depletion (dehydration, vomiting, diarrhea) 1, 2

Step 2: Measure Serum EPO Level (Key Discriminator)

  • Low or inappropriately normal EPO → suggests polycythemia vera or PFCP 1, 3, 2
  • Elevated EPO → suggests secondary polycythemia 1, 3, 2

Critical nuance: In chronic hypoxic states, EPO may normalize after hemoglobin stabilizes at a compensatory higher level, potentially mimicking primary polycythemia. 3

Step 3: If EPO Low/Normal → Test for Primary Polycythemia

  • JAK2 V617F mutation testing (present in up to 97% of polycythemia vera) 1, 3, 2
  • Bone marrow examination showing hypercellularity, abnormal megakaryocytes, and decreased iron stores confirms polycythemia vera 1, 2
  • Consider EPOR gene mutation testing for familial cases with low EPO 4, 5

Step 4: If EPO Elevated → Evaluate for Hypoxia

  • Arterial blood gas analysis or pulse oximetry to assess oxygenation 1, 3, 2
  • Chest X-ray to evaluate for chronic lung disease 1, 3, 2
  • Echocardiography to assess for cyanotic congenital heart disease with right-to-left shunting 6
  • Sleep study if hypoventilation syndrome or obstructive sleep apnea suspected 3

Step 5: If EPO Elevated Without Hypoxia → Screen for Tumors

  • Abdominal ultrasound or CT to screen for renal cell carcinoma, hepatocellular carcinoma, or other EPO-producing tumors 1, 3, 2

Step 6: Consider Congenital Causes in Young Patients

  • Hemoglobin electrophoresis for high oxygen-affinity hemoglobinopathy 1, 2
  • Genetic testing for VHL gene mutations, EPOR mutations, or 2,3-BPG mutase deficiency 1, 4, 5

Common Pitfalls to Avoid

  • Failing to distinguish relative from true polycythemia leads to unnecessary hematologic workup 3
  • Overlooking iron deficiency in cyanotic heart disease: Iron-deficient microcytic red cells worsen tissue oxygenation despite elevated hematocrit, creating a vicious cycle 6
  • Misinterpreting normal EPO in chronic hypoxic states: EPO may normalize after hemoglobin stabilizes, mimicking primary polycythemia 3
  • Assuming polycythemia vera without checking EPO levels: Always measure EPO before pursuing JAK2 testing or bone marrow examination 3, 2
  • Aggressive phlebotomy in secondary polycythemia: Risks iron depletion, decreased oxygen-carrying capacity, and paradoxically increased stroke risk 3

References

Guideline

Polycythemia Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach and Management of Polycythemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Secondary Polycythemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Congenital and acquired polycythemias.

Deutsches Arzteblatt international, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.